Pharmacological chromatin remodeling enhances response to estrogen therapy in ER(+) breast cancer.
Journal: Molecular oncology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Johnson Thomas AL, Karakyriakou B, Muskus PC, et al. (2026). "Pharmacological chromatin remodeling enhances response to estrogen therapy in ER(+) breast cancer.". Molecular oncology. https://doi.org/10.1002/1878-0261.70307